Kim Yeshin, Suh Yeon Lim, Kim Seung Joo, Bae Moon Hwan, Kim Jae Bum, Kim Yuna, Choi Kyung Chan, Huh Gi Yeong, Kim Eun Joo, Lee Jung Seok, Kang Hyun Wook, Shim Sung Mi, Lim Hyun Joung, Koh Young Ho, Kim Byeong Chae, Lee Kyung Hwa, Lee Min Cheol, Lee Ho Won, Lim Tae Sung, Seeley William W, Kim Hee Jin, Na Duk L, Lee Kyung Hoon, Seo Sang Won
Department of Neurology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, Korea.
Yonsei Med J. 2018 Dec;59(10):1197-1204. doi: 10.3349/ymj.2018.59.10.1197.
Obtaining brain tissue is critical to definite diagnosis and to furthering understanding of neurodegenerative diseases. The present authors have maintained the National Neuropathology Reference and Diagnostic Laboratories for Dementia in South Korea since 2016. We have built a nationwide brain bank network and are collecting brain tissues from patients with neurodegenerative diseases. We are aiming to facilitate analyses of clinic-pathological and image-pathological correlations of neurodegenerative disease and to broaden understanding thereof.
We recruited participants through two routes: from memory clinics and the community. As a baseline evaluation, clinical interviews, a neurological examination, laboratory tests, neuropsychological tests, and MRI were undertaken. Some patients also underwent amyloid PET.
We recruited 105 participants, 70 from clinics and 35 from the community. Among them, 11 died and were autopsied. The clinical diagnoses of the autopsied patients included four with Alzheimer's disease (AD), two with subcortical vascular dementia, two with non-fluent variant primary progressive aphasia, one with leukoencephalopathy, one with frontotemporal dementia (FTD), and one with Creutzfeldt-Jakob disease (CJD). Five patients underwent amyloid PET: two with AD, one with mixed dementia, one with FTD, and one with CJD.
The clinical and neuropathological information to be obtained from this cohort in the future will provide a deeper understanding of the neuropathological mechanisms of cognitive impairment in Asia, especially Korea.
获取脑组织对于明确诊断和加深对神经退行性疾病的理解至关重要。自2016年以来,本文作者一直在韩国维持国家痴呆症神经病理学参考与诊断实验室。我们建立了一个全国性的脑库网络,并正在收集神经退行性疾病患者的脑组织。我们旨在促进对神经退行性疾病临床病理和影像病理相关性的分析,并拓宽对此的理解。
我们通过两种途径招募参与者:来自记忆诊所和社区。作为基线评估,进行了临床访谈、神经系统检查、实验室检查、神经心理学测试和磁共振成像(MRI)。一些患者还接受了淀粉样蛋白正电子发射断层扫描(PET)。
我们招募了105名参与者,其中70名来自诊所,35名来自社区。其中,11人死亡并接受了尸检。尸检患者的临床诊断包括4例阿尔茨海默病(AD)、2例皮质下血管性痴呆、2例非流利型原发性进行性失语、1例白质脑病、1例额颞叶痴呆(FTD)和1例克雅氏病(CJD)。5名患者接受了淀粉样蛋白PET检查:2例AD、1例混合性痴呆、1例FTD和1例CJD。
未来从该队列中获得的临床和神经病理学信息将有助于更深入地了解亚洲尤其是韩国认知障碍的神经病理学机制。